The evolution of Taiwan’s National Health Insurance drug reimbursement scheme

Por Hsu, Jason C, Lu, Christine Y
Publicado no Daru (2015)

Longitudinal trends in use and costs of targeted therapies for common cancers in Taiwan: a retrospective observational study

Por Hsu, Jason C, Lu, Christine Y
Publicado no BMJ Open (2016)

The funding and use of high-cost medicines in Australia: the example of anti-rheumatic biological medicines

Por Lu, Christine Y, Williams, Kenneth M, Day, Richard O
Publicado em 2007

The views of stakeholders on controlled access schemes for high-cost antirheumatic biological medicines in Australia

Por Lu, Christine Y, Ritchie, Jan, Williams, Ken, Day, Ric
Publicado em 2007

Access to high cost medicines in Australia: ethical perspectives

Por Lu, Christine Y, Macneill, Paul, Williams, Ken, Day, Ric
Publicado em 2008

Access to Orphan Drugs: A Comprehensive Review of Legislations, Regulations and Policies in 35 Countries

Por Gammie, Todd, Lu, Christine Y., Babar, Zaheer Ud-Din
Publicado no PLoS One (2015)

Recent developments in targeting access to high cost medicines in Australia

Por Lu, Christine Y, Ritchie, Jan, Williams, Kenneth M, Day, Richard O
Publicado em 2005

Interventions designed to improve the quality and efficiency of medication use in managed care: A critical review of the literature – 2001–2007

Por Lu, Christine Y, Ross-Degnan, Dennis, Soumerai, Stephen B, Pearson, Sallie-Anne
Publicado em 2008

Access to high cost drugs in Australia: Risk sharing scheme may set a new paradigm

Por Lu, Christine Y, Williams, Ken, Day, Ric, March, Lyn, Sansom, Lloyd, Bertouch, James
Publicado em 2004

Policies and Programs to Facilitate Access to Targeted Cancer Therapies in Thailand

Por Sruamsiri, Rosarin, Ross-Degnan, Dennis, Lu, Christine Y., Chaiyakunapruk, Nathorn, Wagner, Anita K.
Publicado no PLoS One (2015)

Net Clinical Benefit of Oral Anticoagulants: A Multiple Criteria Decision Analysis

Por Hsu, Jason C., Hsieh, Cheng-Yang, Yang, Yea-Huei Kao, Lu, Christine Y.
Publicado no PLoS One (2015)

Longitudinal trends in use of targeted therapies for treatment of malignant neoplasms of the eye: a population-based study in Taiwan

Por Hsu, Jason C, Gonzalez-Gonzalez, Luis A, Lu, Vicky H, Lu, Christine Y
Publicado no BMJ Open (2016)

Missing clinical and behavioral health data in a large electronic health record (EHR) system

Por Madden, Jeanne M, Lakoma, Matthew D, Rusinak, Donna, Lu, Christine Y, Soumerai, Stephen B
Publicado no J Am Med Inform Assoc (2016)

How Did Multiple FDA Actions Affect the Utilization and Reimbursed Costs of Thiazolidinediones in US Medicaid?

Por Hsu, Jason C., Ross-Degnan, Dennis, Wagner, Anita K., Zhang, Fang, Lu, Christine Y.
Publicado no Clin Ther (2015)

Uptake of new antidiabetic medications in three emerging markets: a comparison between Brazil, China and Thailand

Por Lu, Christine Y, Emmerick, Isabel Cristina M, Stephens, Peter, Ross-Degnan, Dennis, Wagner, Anita K
Publicado no J Pharm Policy Pract (2015)

Association Between Prior Authorization for Psychiatric Medications and Use of Health Services Among Medicaid Patients With Bipolar Disorder

Por Lu, Christine Y, Adams, Alyce S, Ross-Degnan, Dennis, Zhang, Fang, Zhang, Yuting, Salzman, Carl, Soumerai, Stephen B
Publicado em 2011

Patient access schemes in Asia-pacific markets: current experience and future potential

Por Lu, Christine Y, Lupton, Caitlin, Rakowsky, Shana, Babar, Zaheer-Ud-Din, Ross-Degnan, Dennis, Wagner, Anita K
Publicado no J Pharm Policy Pract (2015)

Expanding access to high-cost medicines through the E2 access program in Thailand: effects on utilisation, health outcomes and cost using an interrupted time-series analysis

Por Sruamsiri, Rosarin, Wagner, Anita K, Ross-Degnan, Dennis, Lu, Christine Y, Dhippayom, Teerapon, Ngorsuraches, Surachat, Chaiyakunapruk, Nathorn
Publicado no BMJ Open (2016)

Utilization of oral antidiabetic medications in Taiwan following strategies to promote access to medicines for chronic diseases in community pharmacies

Por Hsu, Jason C, Ross-Degnan, Dennis, Wagner, Anita K, Cheng, Ching-Lan, Yang, Yea-Huei Kao, Zhang, Fang, Lu, Christine Y
Publicado no J Pharm Policy Pract (2015)

Use and outcomes of targeted therapies in early and metastatic HER2-positive breast cancer in Australia: protocol detailing observations in a whole of population cohort

Por Daniels, Benjamin, Lord, Sarah J, Kiely, Belinda E, Houssami, Nehmat, Haywood, Philip, Lu, Christine Y, Ward, Robyn L, Pearson, Sallie-Anne
Publicado no BMJ Open (2017)